N Mygind. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Administration, TopicalAdrenergic alpha-Agonists/therapeutic useAdrenergic beta-Agonists/therapeutic useAnimalsAnti-Inflammatory Agents/therapeutic useBasophils/immunologyCalcium Channel Blockers/therapeutic useCromolyn Sodium/therapeutic useGlucocorticoidsHaplorhiniHistamine H1 Antagonists/therapeutic useHumansHypnotics and Sedatives/therapeutic useMast Cells/immunologyNasal Mucosa/anatomy & histologyNasal Mucosa/blood supplyNasal Mucosa/innervationNasal Provocation TestsNeuromuscular Blocking Agents/therapeutic useParasympathetic Nervous System/blood supplyRhinitis, Allergic, Perennial/drug therapyRhinitis, Allergic, Perennial/metabolismRhinitis, Allergic, Perennial/physiopathologyRhinitis, Allergic, Seasonal/drug therapyRhinitis, Allergic, Seasonal/metabolismRhinitis, Allergic, Seasonal/physiopathologySympathetic Nervous System/blood supply
Substances: See more » Adrenergic alpha-AgonistsAdrenergic beta-AgonistsAnti-Inflammatory AgentsCalcium Channel BlockersGlucocorticoidsHistamine H1 AntagonistsHypnotics and SedativesNeuromuscular Blocking AgentsCromolyn Sodium
Year: 1982 PMID: 6125534 DOI: 10.1016/0091-6749(82)90036-7
Source DB: PubMed Journal: J Allergy Clin Immunol ISSN: 0091-6749 Impact factor: 10.793